Total number of protein in "GO:0030669" GO term: 67
Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADRB2-201 | ADRB2 | P07550 | Beta-2 adrenergic receptor | chr5 | GO:0030669 | Not Cancer Driver | No | 36 | 0.0871670702179176 | 35 | 4 | 0.009685230024213 | 0 |
AP2A1-202 | AP2A1 | O95782 | AP-2 complex subunit alpha-1 | chr19 | GO:0030669 | Not Cancer Driver | No | 75 | 0.0767656090071648 | 188 | 10 | 0.0102354145342886 | 0 |
AP2A2-202 | AP2A2 | O94973 | AP-2 complex subunit alpha-2 | chr11 | GO:0030669 | Not Cancer Driver | No | 77 | 0.0820021299254526 | 145 | 10 | 0.0106496272630457 | 0 |
AP2B1-221 | AP2B1 | P63010 | AP-2 complex subunit beta | chr17 | GO:0030669 | Not Cancer Driver | No | 80 | 0.0853788687299893 | 95 | 8 | 0.0085378868729989 | 0 |
AP2M1-201 | AP2M1 | Q96CW1 | AP-2 complex subunit mu | chr3 | GO:0030669 | Not Cancer Driver | No | 40 | 0.0919540229885057 | 41 | 7 | 0.0160919540229885 | 1 |
AP2S1-201 | AP2S1 | P53680 | AP-2 complex subunit sigma | chr19 | GO:0030669 | Not Cancer Driver | No | 5 | 0.0352112676056338 | 0 | 0 | 0.0 | 1 |
APOB-201 | APOB | P04114 | Apolipoprotein B-100 | chr2 | GO:0030669 | Not Cancer Driver | No | 795 | 0.1742274819197896 | 317 | 51 | 0.0111768573307034 | 3 |
APOE-201 | APOE | P02649 | Apolipoprotein E | chr19 | GO:0030669 | Not Cancer Driver | No | 20 | 0.0630914826498422 | 124 | 5 | 0.0157728706624605 | 10 |
AREG-201 | AREG | P15514 | Amphiregulin | chr4 | GO:0030669 | Not Cancer Driver | No | 33 | 0.1309523809523809 | 152 | 26 | 0.1031746031746031 | 0 |
AVP-201 | AVP | P01185 | Vasopressin-neurophysin 2-copeptin | chr20 | GO:0030669 | Not Cancer Driver | No | 11 | 0.0670731707317073 | 26 | 1 | 0.0060975609756097 | 26 |
AVPR2-205 | AVPR2 | P30518 | Vasopressin V2 receptor | chrX | GO:0030669 | Not Cancer Driver | No | 51 | 0.137466307277628 | 56 | 8 | 0.0215633423180593 | 70 |
BTC-201 | BTC | P35070 | Probetacellulin | chr4 | GO:0030669 | Not Cancer Driver | No | 23 | 0.1292134831460674 | 12 | 5 | 0.0280898876404494 | 0 |
CD207-201 | CD207 | Q9UJ71 | C-type lectin domain family 4 member K | chr2 | GO:0030669 | Not Cancer Driver | No | 55 | 0.1676829268292683 | 58 | 10 | 0.0304878048780487 | 1 |
CD3D-201 | CD3D | P04234 | T-cell surface glycoprotein CD3 delta chain | chr11 | GO:0030669 | Not Cancer Driver | No | 19 | 0.1111111111111111 | 2 | 1 | 0.0058479532163742 | 0 |
CD3G-206 | CD3G | P09693 | T-cell surface glycoprotein CD3 gamma chain | chr11 | GO:0030669 | Not Cancer Driver | No | 15 | 0.0824175824175824 | 49 | 5 | 0.0274725274725274 | 0 |
CD4-201 | CD4 | P01730 | T-cell surface glycoprotein CD4 | chr12 | GO:0030669 | Not Cancer Driver | No | 50 | 0.1091703056768559 | 56 | 7 | 0.0152838427947598 | 0 |
CD74-201 | CD74 | P04233 | HLA class II histocompatibility antigen gamma chain | chr5 | GO:0030669 | Census | Yes | 24 | 0.081081081081081 | 186 | 15 | 0.0506756756756756 | 0 |
CD9-201 | CD9 | P21926 | CD9 antigen | chr12 | GO:0030669 | Not Cancer Driver | No | 19 | 0.0833333333333333 | 0 | 0 | 0.0 | 0 |
CFTR-201 | CFTR | P13569 | Cystic fibrosis transmembrane conductance regulator | chr7 | GO:0030669 | Not Cancer Driver | No | 216 | 0.1459459459459459 | 145 | 9 | 0.006081081081081 | 130 |
CHRM2-208 | CHRM2 | P08172 | Muscarinic acetylcholine receptor M2 | chr7 | GO:0030669 | Not Cancer Driver | No | 186 | 0.3991416309012875 | 169 | 77 | 0.1652360515021459 | 0 |
CLTC-201 | CLTC | Q00610 | Clathrin heavy chain 1 | chr17 | GO:0030669 | Census, Compendium | Yes | 132 | 0.0788059701492537 | 71 | 5 | 0.0029850746268656 | 1 |
EGF-201 | EGF | P01133 | Pro-epidermal growth factor | chr4 | GO:0030669 | Not Cancer Driver | No | 149 | 0.1234465617232808 | 193 | 22 | 0.0182270091135045 | 1 |
EGFR-201 | EGFR | P00533 | Epidermal growth factor receptor | chr7 | GO:0030669 | Census, Compendium | Yes | 346 | 0.2859504132231405 | 223 | 30 | 0.024793388429752 | 1 |
ENST00000498285 | VAMP2 | P63027 | Vesicle-associated membrane protein 2 | chr17 | GO:0030669 | Not Cancer Driver | No | 3 | 0.024793388429752 | 60 | 1 | 0.0082644628099173 | 3 |
EPGN-202 | EPGN | Q6UW88 | Epigen | chr4 | GO:0030669 | Not Cancer Driver | No | 11 | 0.0714285714285714 | 0 | 0 | 0.0 | 0 |
EREG-201 | EREG | O14944 | Proepiregulin | chr4 | GO:0030669 | Not Cancer Driver | No | 19 | 0.1124260355029585 | 10 | 2 | 0.0118343195266272 | 0 |
FCGR1A-201 | FCGR1A | P12314 | High affinity immunoglobulin gamma Fc receptor I | chr1 | GO:0030669 | Not Cancer Driver | No | 43 | 0.1149732620320855 | 37 | 4 | 0.0106951871657754 | 0 |
FZD2-201 | FZD2 | Q14332 | Frizzled-2 | chr17 | GO:0030669 | Not Cancer Driver | No | 73 | 0.1292035398230088 | 47 | 6 | 0.0106194690265486 | 2 |
FZD4-201 | FZD4 | Q9ULV1 | Frizzled-4 | chr11 | GO:0030669 | Not Cancer Driver | No | 40 | 0.074487895716946 | 33 | 5 | 0.0093109869646182 | 17 |
FZD5-201 | FZD5 | Q13467 | Frizzled-5 | chr2 | GO:0030669 | Not Cancer Driver | No | 39 | 0.0666666666666666 | 58 | 3 | 0.0051282051282051 | 0 |
HBEGF-201 | HBEGF | Q99075 | Proheparin-binding EGF-like growth factor | chr5 | GO:0030669 | Not Cancer Driver | No | 11 | 0.0528846153846153 | 63 | 2 | 0.0096153846153846 | 0 |
HLA-DPA1-248 | HLA-DPA1 | P20036 | HLA class II histocompatibility antigen, DP alpha 1 chain | chr6 | GO:0030669 | Not Cancer Driver | No | 22 | 0.0846153846153846 | 30 | 3 | 0.0115384615384615 | 0 |
HLA-DPB1-211 | HLA-DPB1 | P04440 | HLA class II histocompatibility antigen, DP beta 1 chain | chr6 | GO:0030669 | Not Cancer Driver | No | 14 | 0.0542635658914728 | 39 | 4 | 0.0155038759689922 | 0 |
HLA-DQA2-210 | HLA-DQA2 | P01906 | HLA class II histocompatibility antigen, DQ alpha 2 chain | chr6 | GO:0030669 | Not Cancer Driver | No | 44 | 0.1725490196078431 | 7 | 0 | 0.0 | 0 |
HLA-DQB1-205 | HLA-DQB1 | P01920 | HLA class II histocompatibility antigen, DQ beta 1 chain | chr6 | GO:0030669 | Not Cancer Driver | No | 17 | 0.0651340996168582 | 25 | 1 | 0.003831417624521 | 0 |
HLA-DQB2-232 | HLA-DQB2 | P05538 | HLA class II histocompatibility antigen, DQ beta 2 chain | chr6 | GO:0030669 | Not Cancer Driver | No | 17 | 0.0643939393939393 | 38 | 2 | 0.0075757575757575 | 0 |
HLA-DRA-202 | HLA-DRA | P01903 | HLA class II histocompatibility antigen, DR alpha chain | chr6 | GO:0030669 | Not Cancer Driver | No | 43 | 0.1692913385826771 | 12 | 2 | 0.0078740157480314 | 0 |
HLA-DRB1-201 | HLA-DRB1 | P01911 | HLA class II histocompatibility antigen, DRB1 beta chain | chr6 | GO:0030669 | Not Cancer Driver | No | 11 | 0.0413533834586466 | 12 | 0 | 0.0 | 0 |
HLA-DRB5-201 | HLA-DRB5 | Q30154 | HLA class II histocompatibility antigen, DR beta 5 chain | chr6 | GO:0030669 | Not Cancer Driver | No | 7 | 0.0263157894736842 | 19 | 0 | 0.0 | 0 |
IGF2R-201 | IGF2R | P11717 | Cation-independent mannose-6-phosphate receptor | chr6 | GO:0030669 | Not Cancer Driver | No | 233 | 0.0935367322360497 | 257 | 13 | 0.0052187876354877 | 0 |
IL7R-201 | IL7R | P16871 | Interleukin-7 receptor subunit alpha | chr5 | GO:0030669 | Census, Compendium | Yes | 140 | 0.3050108932461873 | 89 | 40 | 0.0871459694989106 | 1 |
KIAA0319-201 | KIAA0319 | Q5VV43 | Dyslexia-associated protein KIAA0319 | chr6 | GO:0030669 | Not Cancer Driver | No | 163 | 0.1520522388059701 | 494 | 73 | 0.0680970149253731 | 0 |
LDLR-208 | LDLR | P01130 | Low-density lipoprotein receptor | chr19 | GO:0030669 | Not Cancer Driver | No | 94 | 0.1093023255813953 | 63 | 3 | 0.0034883720930232 | 87 |
LDLRAP1-201 | LDLRAP1 | Q5SW96 | Low density lipoprotein receptor adapter protein 1 | chr1 | GO:0030669 | Not Cancer Driver | No | 29 | 0.0941558441558441 | 121 | 9 | 0.0292207792207792 | 2 |
LRP2-205 | LRP2 | P98164 | Low-density lipoprotein receptor-related protein 2 | chr2 | GO:0030669 | Not Cancer Driver | No | 740 | 0.158968850698174 | 209 | 26 | 0.0055853920515574 | 1 |
M6PR-201 | M6PR | P20645 | Cation-dependent mannose-6-phosphate receptor | chr12 | GO:0030669 | Not Cancer Driver | No | 12 | 0.0433212996389891 | 35 | 2 | 0.0072202166064981 | 0 |
RAB35-201 | RAB35 | Q15286 | Ras-related protein Rab-35 | chr12 | GO:0030669 | Not Cancer Driver | No | 16 | 0.0796019900497512 | 26 | 1 | 0.0049751243781094 | 0 |
RAB5A-201 | RAB5A | P20339 | Ras-related protein Rab-5A | chr3 | GO:0030669 | Not Cancer Driver | No | 20 | 0.0930232558139534 | 67 | 9 | 0.041860465116279 | 0 |
ROR2-201 | ROR2 | Q01974 | Tyrosine-protein kinase transmembrane receptor ROR2 | chr9 | GO:0030669 | Not Cancer Driver | No | 164 | 0.1739130434782608 | 304 | 58 | 0.0615058324496288 | 5 |
SCARB2-201 | SCARB2 | Q14108 | Lysosome membrane protein 2 | chr4 | GO:0030669 | Not Cancer Driver | No | 46 | 0.0962343096234309 | 13 | 3 | 0.006276150627615 | 1 |
SH3GL2-201 | SH3GL2 | Q99962 | Endophilin-A1 | chr9 | GO:0030669 | Not Cancer Driver | No | 58 | 0.1647727272727272 | 215 | 36 | 0.1022727272727272 | 0 |
SLC18A3-201 | SLC18A3 | Q16572 | Vesicular acetylcholine transporter | chr10 | GO:0030669 | Not Cancer Driver | No | 93 | 0.1748120300751879 | 90 | 15 | 0.0281954887218045 | 2 |
SLC2A8-203 | SLC2A8 | Q9NY64 | Solute carrier family 2, facilitated glucose transporter member 8 | chr9 | GO:0030669 | Not Cancer Driver | No | 22 | 0.0461215932914046 | 20 | 0 | 0.0 | 0 |
SYT1-201 | SYT1 | P21579 | Synaptotagmin-1 | chr12 | GO:0030669 | Not Cancer Driver | No | 89 | 0.2109004739336493 | 103 | 33 | 0.0781990521327014 | 5 |
SYT2-202 | SYT2 | Q8N9I0 | Synaptotagmin-2 | chr1 | GO:0030669 | Not Cancer Driver | No | 50 | 0.1193317422434367 | 142 | 14 | 0.0334128878281622 | 3 |
SYT9-201 | SYT9 | Q86SS6 | Synaptotagmin-9 | chr11 | GO:0030669 | Not Cancer Driver | No | 95 | 0.1934826883910387 | 149 | 32 | 0.065173116089613 | 0 |
TF-201 | TF | P02787 | Serotransferrin | chr3 | GO:0030669 | Not Cancer Driver | No | 94 | 0.1346704871060172 | 21 | 3 | 0.0042979942693409 | 2 |
TFRC-201 | TFRC | P02786 | Transferrin receptor protein 1 | chr3 | GO:0030669 | Census | Yes | 66 | 0.0868421052631579 | 80 | 4 | 0.0052631578947368 | 1 |
TGFA-201 | TGFA | P01135 | Protransforming growth factor alpha | chr2 | GO:0030669 | Not Cancer Driver | No | 17 | 0.10625 | 0 | 0 | 0.0 | 0 |
TGOLN2-201 | TGOLN2 | O43493 | Trans-Golgi network integral membrane protein 2 | chr2 | GO:0030669 | Not Cancer Driver | No | 39 | 0.0892448512585812 | 401 | 33 | 0.0755148741418764 | 0 |
TYRP1-203 | TYRP1 | P17643 | 5,6-dihydroxyindole-2-carboxylic acid oxidase | chr9 | GO:0030669 | Not Cancer Driver | No | 63 | 0.1173184357541899 | 88 | 11 | 0.0204841713221601 | 2 |
VAMP2-201 | VAMP2 | P63027 | Vesicle-associated membrane protein 2 | chr17 | GO:0030669 | Not Cancer Driver | No | 3 | 0.0258620689655172 | 47 | 0 | 0.0 | 3 |
VAMP3-201 | VAMP3 | Q15836 | Vesicle-associated membrane protein 3 | chr1 | GO:0030669 | Not Cancer Driver | No | 8 | 0.08 | 17 | 1 | 0.01 | 0 |
VAMP4-201 | VAMP4 | O75379 | Vesicle-associated membrane protein 4 | chr1 | GO:0030669 | Not Cancer Driver | No | 6 | 0.0425531914893617 | 80 | 2 | 0.0141843971631205 | 0 |
VAMP7-202 | VAMP7 | P51809 | Vesicle-associated membrane protein 7 | chrX | GO:0030669 | Not Cancer Driver | No | 18 | 0.0818181818181818 | 4 | 1 | 0.0045454545454545 | 0 |
VAMP8-201 | VAMP8 | Q9BV40 | Vesicle-associated membrane protein 8 | chr2 | GO:0030669 | Not Cancer Driver | No | 7 | 0.07 | 27 | 1 | 0.01 | 0 |
WNT5A-201 | WNT5A | P41221 | Protein Wnt-5a | chr3 | GO:0030669 | Not Cancer Driver | No | 42 | 0.1105263157894736 | 0 | 0 | 0.0 | 2 |